338 related articles for article (PubMed ID: 30555037)
21. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.
Pallett A; Hand K
J Antimicrob Chemother; 2010 Nov; 65 Suppl 3():iii25-33. PubMed ID: 20876625
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Harris PN; Ferguson JK
Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371
[TBL] [Abstract][Full Text] [Related]
23. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.
Carson C; Naber KG
Drugs; 2004; 64(12):1359-73. PubMed ID: 15200349
[TBL] [Abstract][Full Text] [Related]
24. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH
Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669
[TBL] [Abstract][Full Text] [Related]
25. Urinary tract infections caused by beta-lactam-sensitive Corynebacterium urealyticum strains.
Zapardiel J; Nieto E; Soriano F
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):174-6. PubMed ID: 9105850
[No Abstract] [Full Text] [Related]
26. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
[TBL] [Abstract][Full Text] [Related]
27. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
[TBL] [Abstract][Full Text] [Related]
28. [News of antibiotic resistance among Gram-negative bacilli in Algeria].
Baba Ahmed-Kazi Tani Z; Arlet G
Pathol Biol (Paris); 2014 Jun; 62(3):169-78. PubMed ID: 24819127
[TBL] [Abstract][Full Text] [Related]
29. Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
Garcia-Bustos V; Cabañero-Navalón MD; Salavert Lletí M
Rev Esp Quimioter; 2022 Sep; 35 Suppl 2(Suppl 2):1-15. PubMed ID: 36193979
[TBL] [Abstract][Full Text] [Related]
30. Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
D'Angelo RG; Johnson JK; Bork JT; Heil EL
Expert Opin Pharmacother; 2016; 17(7):953-67. PubMed ID: 26891857
[TBL] [Abstract][Full Text] [Related]
31. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
32. The current state of multidrug-resistant gram-negative bacilli in North America.
Nicasio AM; Kuti JL; Nicolau DP
Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
[TBL] [Abstract][Full Text] [Related]
33. Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.
Gootz TD
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):317-27. PubMed ID: 15482196
[TBL] [Abstract][Full Text] [Related]
34. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
35. [Detection of resistance phenotypes in gram-negative bacteria].
Navarro F; Calvo J; Cantón R; Fernández-Cuenca F; Mirelis B
Enferm Infecc Microbiol Clin; 2011; 29(7):524-34. PubMed ID: 21696863
[TBL] [Abstract][Full Text] [Related]
36. Beta-lactam antibiotics: newer formulations and newer agents.
Martin SI; Kaye KM
Infect Dis Clin North Am; 2004 Sep; 18(3):603-19, ix. PubMed ID: 15308278
[TBL] [Abstract][Full Text] [Related]
37. Parenteral carbapenems.
Shah PM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
[TBL] [Abstract][Full Text] [Related]
38. [New antibiotics for the treatment of urinary tract infections].
Wagenlehner FME
Urologie; 2023 Jul; 62(7):705-710. PubMed ID: 37306723
[TBL] [Abstract][Full Text] [Related]
39. [Recent progress in development of antibiotics against Gram-negative bacteria].
Xu ZQ; Xu ZY
Yao Xue Xue Bao; 2013 Jul; 48(7):993-1004. PubMed ID: 24133966
[TBL] [Abstract][Full Text] [Related]
40. [beta-Lactam antibiotics].
Marín M; Gudiol F
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):42-55. PubMed ID: 12550043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
